Pandis Nikolaos, Chung Bryan, Scherer Roberta W, Elbourne Diana, Altman Douglas G
University of Bern, Medical Faculty, School of Dental Medicine, Department of Orthodontics and Dentofacial Orthopedics, Bern, Switzerland.
Division of Plastic Surgery, University of British Columbia, Victoria, BC, Canada.
BMJ. 2017 Jun 30;357:j2835. doi: 10.1136/bmj.j2835.
Evidence shows that the quality of reporting of randomised controlled trials (RCTs) is not optimal. The lack of transparent reporting impedes readers from judging the reliability and validity of trial findings and researchers from extracting information for systematic reviews and results in research waste. The Consolidated Standards of Reporting Trials (CONSORT) statement was developed to improve the reporting of RCTs. Within person trials are used for conditions that can affect two or more body sites, and are a useful and efficient tool because the comparisons between interventions are within people. Such trials are most commonly conducted in ophthalmology, dentistry, and dermatology. The reporting of within person trials has, however, been variable and incomplete, hindering their use in clinical decision making and by future researchers. This document presents the CONSORT extension to within person trials. It aims to facilitate the reporting of these trials. It extends 16 items of the CONSORT 2010 checklist and introduces a modified flowchart and baseline table to enhance transparency. Examples of good reporting and evidence based rationale for CONSORT within person checklist items are provided.
证据表明,随机对照试验(RCT)的报告质量并不理想。缺乏透明的报告妨碍读者判断试验结果的可靠性和有效性,也妨碍研究人员为系统评价提取信息,从而导致研究资源浪费。制定了《试验报告统一标准》(CONSORT)声明以改善RCT的报告。自身对照试验用于可能影响两个或更多身体部位的病症,是一种有用且高效的工具,因为干预措施之间的比较是在个体内部进行的。此类试验最常在眼科、牙科和皮肤科进行。然而,自身对照试验的报告一直存在差异且不完整,这阻碍了它们在临床决策中的应用以及未来研究人员的使用。本文档介绍了CONSORT对自身对照试验的扩展。其目的是促进这些试验的报告。它扩展了CONSORT 2010清单中的16项内容,并引入了修改后的流程图和基线表以提高透明度。还提供了良好报告的示例以及CONSORT自身对照试验清单项目的循证依据。